Five years' experience with quadruple sequential immunosuppression.
Fischbach
M
M
Service de Pédiatrie 1, Hôpital de Hautepierre, Strasbourg, France.
Wolff
P
P
Tongio
M M
MM
Boudjema
K
K
Christmann
D
D
Steib
A
A
Sauvage
P
P
Desprez
P
P
Mengus
L
L
Simeoni
U
U
D000293:Adolescent; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods* / Q000502:physiology; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D011241:Prednisone